Integration of genomics in the management of refractory juvenile dermatomyositis: towards precision medicine in dermatology. A case study

Authors

DOI:

https://doi.org/10.29176/30284163.2010

Keywords:

genetic syndromes, pediatrics, autoinmune disease, rare disease, exome

Abstract

Juvenile dermatomyositis (JDM) is a multisystemic and autoimmune inflammatory condition with variable and poorly understood etiology. Diagnosis has traditionally relied on clinical presentation, supported by diagnostic aids and laboratory tests. However, genomic studies are gaining increasing importance in better characterizing the role of rare and non-coding genetic variants in various myopathies. This leads to individualized management and clinical presentations of the disease. A clinical case of treatment-refractory juvenile dermatomyositis secondary to common variable immunodeficiency due to a variant in the TNFRSF13B gene is presented. Variants in the TNFRSF13B gene have been associated with diverse pathologies such as common variable immunodeficiency (CVID), selective IgA deficiency, lymphoproliferative disorders, and some autoimmune disorders like systemic lupus erythematosus and dermatomyositis. The comorbidity of CVID and rheumatologic disease has been documented as a poor prognostic factor due to inadequate response to conventional therapies and immunoglobulin replacement therapy, necessitating additional immunomodulatory treatments for managing these conditions. Genomics play a crucial role by enabling genetic sequencing studies and whole exome sequencing. This provides genetic counseling and offers personalized therapeutic options to improve patient prognosis.

Author Biographies

Johan Conquett Huertas, Universidad Libre, Cali, Colombia

Médico residente, posgrado de Dermatología, Universidad Libre, Cali

Lina Johanna Moreno Giraldo, Universidad Libre seccional Cali, Colombia

Médico pediatra. Magíster y doctorado en Ciencias Biomédicas, Genética Médica, Universidad Libre, Cali

References

Plácido Paias R, Veroz González R, Portillo Márquez M. Dermatomiositis juvenil: a propósito de un caso. Rev Pediatr Aten Primaria. 2022;24:181-6.

Álvarez Mena P, Sánchez Villacís L, Bautista Benavides P, Manzano Pérez V, Zambrano Jordán D. Dermatomiositis juvenil. Sistematización de casos. Revista Cubana de Reumatología. 2019;21(2):1-4.

DeWane ME, Waldman R, Lu J. Dermatomyositis: Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82(2):267-81. https://doi.org/10.1016/j.jaad.2019.06.1309

Lamb JA. The genetics of autoimmune myositis. Front Immunol. 2022;13:886290. https://doi.org/10.3389/fimmu.2022.886290

Ou X, Xu S, Lam KP. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Proc Natl Acad Sci U S A. 2012;109(38):15401-6. https://doi.org/10.1073/pnas.1200386109

Paradoa Pérez ML, Andreu Malda HI, Pérez Martín OG. Inmunodeficiencia Común Variable. Reporte de un caso. Revista Cubana de Genética Comunitaria. 2019;11(3).

National Center for Biotechnology Information. ClinVar; [VCV000005302.79] [Internet]. NCBI. Septiembre de 2024. Disponible en: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000005302.79.

Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol 2019;123(5):454-60. https://doi.org/10.1016/j.anai.2019.07.014

Gutierrez MJ, Sullivan KE, Fuleihan R, USIDNET Consortium; Bingham CO 3rd. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018;48(2):318-26. https://doi.org/10.1016/j.semarthrit.2018.02.013

Ameratunga R, Allan C, Woon ST. Defining common variable immunodeficiency disorders in 2020. Immunol Allergy Clin North Am. 2020;40(3):403-20. https://doi.org/10.1016/j.iac.2020.03.001

de Valles-Ibáñez G, Esteve-Solé A, Piquer M, González-Navarro EA, Hernandez-Rodriguez J, Laayouni H, et al. Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond. Front Immunol. 2018;9:636.12. https://doi.org/10.3389/fimmu.2018.00636

How to Cite

1.
Conquett Huertas J, Moreno Giraldo LJ. Integration of genomics in the management of refractory juvenile dermatomyositis: towards precision medicine in dermatology. A case study. Rev. Hispano-Am. Dermatol. Pediátr. [Internet]. 2025 Feb. 25 [cited 2026 Jan. 15];2(1):41-5. Available from: https://revistaasocoldermaorgco.biteca.online/index.php/dermaped/article/view/2010

Downloads

Download data is not yet available.

Published

2025-02-25

How to Cite

1.
Conquett Huertas J, Moreno Giraldo LJ. Integration of genomics in the management of refractory juvenile dermatomyositis: towards precision medicine in dermatology. A case study. Rev. Hispano-Am. Dermatol. Pediátr. [Internet]. 2025 Feb. 25 [cited 2026 Jan. 15];2(1):41-5. Available from: https://revistaasocoldermaorgco.biteca.online/index.php/dermaped/article/view/2010

Issue

Section

Case report